Page last updated: 2024-10-26

etazolate and Demyelinating Diseases

etazolate has been researched along with Demyelinating Diseases in 2 studies

Etazolate: A potent phosphodiesterase inhibitor proposed as an antipsychotic agent.
etazolate : A pyrazolopyridine that is 1H-pyrazolo[3,4-b]pyridine which is substituted at positions 1, 4, and 5 by ethyl, 2-isopropylidenehydrazino, and ethoxycarbonyl groups, respectively. A phosphodiesterase IV inhibitor with antidepressant and anxiolytic properties.

Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.

Research Excerpts

ExcerptRelevanceReference
"Demyelination is a well-known pathological process in CNS disorders such as multiple sclerosis (MS)."1.62Effect of Etazolate upon Cuprizone-induced Demyelination In Vivo: Behavioral and Myelin Gene Analysis. ( Carrete, A; Jafarian-Tehrani, M; Meffre, D; Padilla-Ferrer, A; Simon, A, 2021)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Carrete, A2
Padilla-Ferrer, A1
Simon, A2
Meffre, D2
Jafarian-Tehrani, M2
Llufriu-Dabén, G1
Chierto, E1
Mailleux, J1
Camand, E1
Vanmierlo, T1
Rose, C1
Allinquant, B1
Hendriks, JJA1
Massaad, C1

Other Studies

2 other studies available for etazolate and Demyelinating Diseases

ArticleYear
Effect of Etazolate upon Cuprizone-induced Demyelination In Vivo: Behavioral and Myelin Gene Analysis.
    Neuroscience, 2021, 02-10, Volume: 455

    Topics: Animals; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Etazolate; Mice; Mice, Inbred C5

2021
Targeting demyelination via α-secretases promoting sAPPα release to enhance remyelination in central nervous system.
    Neurobiology of disease, 2018, Volume: 109, Issue:Pt A

    Topics: Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Axons; Brain; Cells,

2018